New market study, "Forecast Insight: Antibacterials", has been published

April 17, 2011 - PRLog -- Introduction

Over the next decade, the fragmented antibacterials market will shift away from a blockbuster-business model, as generic erosion of market leaders and increased competition between new hospital drugs will trigger a decline in sales of branded antibacterials. While there is a lack of innovation with regards to new community drugs, the hospital sector will remain the only notable source of growth.

Features and benefits

* Analysis of the antibacterials market across the US, Japan, France, Italy, Germany, Spain and the UK.
* Detailed ten-year sales forecasts for marketed antibacterial drugs in each of the seven major markets.
* Thorough assessments of key marketed antibacterial brands.
* Snapshot of market dynamics in the Rest of World.

Highlights

In 2009, antibacterial sales in the seven major markets totalled $19.6bn, declining at a compound annual growth rate (CAGR) of -1.6% since 2005. This decline was largely caused by generic erosion of market-leading community brands, such as Zithromax and Klacid, combined with a paucity of new product launches.
Over the next decade, genericization of key brands will drive a significant decline in market value, contributing to a loss of revenues from Levaquin/Cravit/Tavanic, Zosyn/Tazocin, and Zyvox alone of $3.2bn by 2019. Combined with growing resistance, this will cause increasing market fragmentation and reduce the potential for "blockbuster" sales.
The late-stage pipeline, much of which is targeting MRSA, will generate revenues totaling nearly $2.0bn by 2019. However, Datamonitor predicts that this upside will be insufficient to offset the decline caused by genericization, and total seven major market sales will fall from $19.6bn in 2009 to $16.4bn in 2019, with a CAGR of -1.8%.

Your key questions answered

* Assess and quantify the market opportunity for antibacterials, from generics to high-priced hospital brands.
* Understand the changing market dynamics of antibacterial drugs and success factors for leading brands.
* Assess the impact of key issues affecting the antibacterials market; generic erosion and growing levels of resistance.


For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/149121_forecast_insight_antiba...

About Datamonitor

The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment.  View more research from Datamonitor at http://www.fastmr.com/catalog/publishers.aspx?pubid=1002

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.